A Cost-Utility Analysis of Losartan versus Atenolol in the Treatment of Hypertension with Left Ventricular Hypertrophy

By Anis Aslam H.   Sun Huiying  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 387-400

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in Patients with Acute Coronary Syndrome in Poland: Modelling Study from the Hospital Perspective

By Orlewska E.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 737-748

Adis International

Access to resources Recommend Favorite

Effects of Losartan on Fibrinolytic Parameters and von Willebrand Factor in Chinese Subjects with Hypertension: a Comparative Study versus Atenolol

By Liu J   Sun N-L   Yang J   Huang J-H  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 595-600

Field House Publishing

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus Cyclophosphamide

By Liubao Peng  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 873-886

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of a Lidocaine 5% Medicated Plaster Compared with Gabapentin and Pregabalin for Treating Postherpetic Neuralgia: A German Perspective

By Liedgens Hiltrud  

Clinical Drug Investigation, Vol. 28, Iss. 9, 2008-01 ,pp. : 583-601

Adis International

Access to resources Recommend Favorite